MBL77 NO FURTHER A MYSTERY

mutations provided The reality that, as stated down below, CLL therapy is predicated to the existence or absence of those mutations. The present consensus is that, aside from clonal mutations, subclonal mutations using a variant allelic frequency ranging from five to ten% (and therefore below the brink of detection by standard molecular procedures)